2011-02-15T14:50:14-06:00 2010-06-30 BDO USA LLP 100 PARK AVENUE NEW YORK NY 10017 990 2009-07-01 131673104 NATIONAL KIDNEY FOUNDATION INC NATI 2128892210 30 EAST 33RD STREET NEW YORK NY 10016 THOMAS MARTIN 2011-02-15 Paul Hammerschmidt 2128858000 2009 2016-02-24 21:20:13Z JOHN R DAVIS 30 EAST 33RD STREET NEW YORK NY 10016 62425830 false X WWW.KIDNEY.ORG X 1950 NY TO PREVENT KIDNEY AND URINARY TRACT DISEASES, IMPROVE THE HEALTH AND WELL-BEING OF INDIVIDUALS AND FAMILIES AFFECTED BY THESE DISEASES, AND INCREASE THE AVAILABILITY OF ALL ORGANS FOR TRANSPLANTATION. 30 29 484 31500 0 31411499 29176465 17269746 15462449 -5263340 -1129269 1908646 2630746 45326551 46140391 4528353 4775640 0 0 19631214 21241556 143978 995431 5039313 30278248 25509082 54581793 52521709 -9255242 -6381318 21838662 21269550 11230250 16291776 10608412 4977774 NATIONAL KIDNEY FOUNDATION'S MISSION IS TO PREVENT KIDNEY AND URINARY TRACT DISEASES, IMPROVE THE HEALTH AND WELL-BEING OF INDIVIDUALS AND FAMILIES AFFECTED BY THESE DISEASES, AND INCREASE THE AVAILABILITY OF ALL ORGANS FOR TRANSPLANTATION. THE ORGANIZATION CONDUCTS NATIONWIDE EDUCATIONAL CAMPAIGNS ABOUT THE ROLE OF THE KIDNEY IN MAINTAINING OVERALL HEALTH, THE IMPORTANCE OF EARLY DETECTION AND ORGAN DONATION AND TRANSPLANTATION. false false 11810620 10922 2145590 COMMUNITY SERVICES AND ASSISTANCE TO AFFILIATES - THE ORGANIZATION'S KIDNEY EARLY EVALUATION PROGRAM (KEEP) SCREENS INDIVIDUALS MOST AT RISK OF POTENTIAL MEDICAL CONDITIONS THAT MAY LEAD TO FUTURE KIDNEY DISEASE. MORE THAN 1,250 PEOPLE WITH HIGH BLOOD PRESSURE, DIABETES OR A FAMILY HISTORY OF KIDNEY DISEASE PARTICIPATE IN THIS FREE KIDNEY DISEASE SCREENING PROGRAM EVERY MONTH IN CITIES AROUND THE U.S. AS A RESULT, MANY LEARNED THAT THEY HAD EARLY KIDNEY DAMAGE AND BEGAN TAKING STEPS TO SAVE THEIR HEALTH, INCLUDING MONITORING BLOOD PRESSURE AND BLOOD GLUCOSE LEVELS, CHANGING THEIR DIET AND MEDICATION. ASSISTANCE IS PROVIDED BY THE ORGANIZATION TO ITS AFFILIATES. THE ORGANIZATION PROVIDES CONSULTATION, GUIDANCE, TRAINING AND LEADERSHIP. SPECIFIC GUIDANCE IS PROVIDED WITH INSTRUCTION BOOKLETS DEALING WITH PATIENT TRANSPORTATION PROGRAMS, DRUG & BLOOD BANKS AND SCREENING AND DETECTION PROGRAMS. AFFILIATES ARE KEPT UP TO DATE WITH CURRENT PUBLICATIONS FROM THE ORGANIZATION. 11514808 15432 10235873 PROFESSIONAL EDUCATION - THE ORGANIZATION OFFERS MULTIDISCIPLINARY PROGRAMS TO THE ENTIRE KIDNEY HEALTH CARE COMMUNITY. THERE ARE MOSTLY NATIONAL MEETINGS OFFERING A WIDE RANGE OF TOPICS AS WELL AS FOCUSED LOCAL/REGIONAL SEMINARS. THE SPRING CLINICAL NEPHROLOGY MEETING HAS GROWN INTO THE NEPHROLOGY COMMUNITY'S PREMIER LEARNING EXPERIENCE WITH OVER 3,000 HEALTHCARE PROFESSIONALS IN ATTENDANCE. APPROXIMATELY 300 POSTERS WERE PRESENTED, AND THIS MEETING ALSO SAW THE HIGHEST-EVER PARTICIPATION IN THE INTERNAL MEDICINE AND PEDIATRIC TRAINEES PROGRAM. THERE WAS ALSO AN ADVANCED PRACTITIONER PROGRAM, DESIGNED SPECIFICALLY FOR PHYSICIAN ASSISTANTS AND NURSE PRACTITIONERS, A GROUP THAT IS NOW CARING FOR KIDNEY PATIENTS ON THE FRONT LINES. SINCE 1981, THE ORGANIZTAION HAS PUBLISHED PEER-REVIEWED JOURNALS THAT PROVIDE TIMELY INSIGHTS AND INFORMATION ON KIDNEY DISEASE AND RELATED RESEARCH TO THE GLOBAL KIDNEY COMMUNITY. THREE OF THE PRESTIGIOUS MEDICAL JOURNALS PUBLISHED BY THE ORGANIZATION JOINED SCIENCEDIRECT, THE PREMIER WEB DISTRIBUTOR OF PROFESSIONAL LEVEL SCIENTIFIC AND MEDICAL INFORMATION. WITH MORE THAN 11 MILLION USERS ACCESSING THE SITE, THE JOURNALS REACHED A LARGER AUDIENCE THAN EVER BEFORE. THE ORGANIZATION'S LEARNING SYSTEM CONTINUED TO PROVIDE COMPREHENSIVE EDUCATION ABOUT CHRONIC KIDNEY DISEASE (CKD) AND HOW TO PREVENT, TREAT AND MANAGE COMPLICATIONS. NEW RESOURCES DEVELOPED IN 2008 FOCUSED ON THE TEAM APPROACH TO TREATING CKD STAGES 4 AND 5 IMPROVING OUTCOMES FOR KIDNEY TRANSPLANT RECIPIENTS. 6705364 1577499 2206403 PATIENT SERVICES - INCLUDE PROGRAMS WHICH PROVIDE MEDICAL JEWELRY, EMERGENCY GRANTS, TRANSPORTATION, SUPPORT GROUPS AND WORKSHOPS FOR KIDNEY PATIENTS. OTHER PROGRAMS INCLUDE PATIENT EDUCATION, CONSTITUENT COUNCIL PROJECTS AND PATIENT EMPOWERMENT INITIATIVES. TO HELP KIDNEY PATIENTS IMPACTED BY NATURAL DISASTERS, THE ORGANIZATION ESTABLISHED A FINANCIAL ASSISTANCE PROGRAM THAT OFFERS SUPPORT AND ENSURES MEDICAL CARE IS NOT COMPROMISED. FUNDS COVERS THE COST OF TRAVEL TO DIALYSIS CENTERS AS WELL AS REPLACEMENT OF DAMAGED POSSESSIONS, HOMES AND BASIC NECESSITIES SUCH AS GROCERIES AND CLOTHING. BEYOND THE MATERIAL SUPPORT, THE ORGANIZATION IS THERE TO HELP KIDNEY PATIENTS COPE WITH THE TRAUMA EXPERIENCED. HUNDREDS OF DIALYSIS PATIENTS TOOK PART IN "PEOPLE LIKE US" STEPPING BACK INTO LIFE, A PROGRAM THAT HELPED THEM DEAL WITH DEPRESSION AND ANXIETY. PARTICIPANTS REPORTED IMPROVEMENTS IN STRESS LEVELS, SOCIAL FUNCTIONING AND OVERALL HEALTH AFTER COMPLETING STEPPING BACK INTO LIFE. 10302331 3171787 1529949 40333123 true false false true false false false false true true false true false false false false false true true false false false true true false false false false false false false false true false false false false true false false false true 181 0 true 484 true false false false false false true true false false false false true 30 29 false false false false false false false true true false true true true true true true true true true true false AL AR CA CO CT DC FL GA IL KS ME MD MA MI MN MS MO NH NJ NM NY NC OH OK OR PA RI SC TN UT VA WA WV WI X X PETROS GREGORIOU 2128892210 30 EAST 33RD STREET NEW YORK NY 10016 JOHN R DAVIS 35.0 X X 404786 0 234722 WILLIAM CELLA 1.0 X X 0 0 0 BRYAN BECKER 1.0 X X 0 0 0 DEBORAH BROMMAGE 1.0 X X 0 0 0 KEN HOWARD 1.0 X X 0 0 0 THOMAS MCDONOUGH 1.0 X 0 0 0 LYNDA SZCZECH 1.0 X 0 0 0 ALLAN COLLINS 1.0 X 0 0 0 JOSEPH ABRUZZESE 1.0 X 0 0 0 TODD BAUR 1.0 X 0 0 0 DEREK BRUCE 1.0 X 0 0 0 ALEXANDER M CAPRON 1.0 X 0 0 0 JAMES CARLSON 1.0 X 0 0 0 JANE DAVIS 1.0 X 0 0 0 THOMAS DAVIS 1.0 X 0 0 0 FRANCIS DELMONICO 1.0 X 0 0 0 WILLIAM DESSOFFY 1.0 X 0 0 0 BRIAN DILSHEIMER 1.0 X 0 0 0 JAY JUSTICE 1.0 X 0 0 0 JOHN KIRKENDALL 1.0 X 0 0 0 DENNIS MORGAN 1.0 X 0 0 0 HOWARD NATHAN 1.0 X 0 0 0 SISTER MICHELE O'BRIEN 1.0 X 0 0 0 RONALD RITTENMEYER 1.0 X 0 0 0 GUY SCALZI 1.0 X 0 0 0 GREGORY SCOTT 1.0 X 0 0 0 MICHAEL SEXTON 1.0 X 0 0 0 RUBEN VALEZ 1.0 X 0 0 0 ED WALTER 1.0 X 0 0 0 MICHAEL WATTS 1.0 X 0 0 0 THOMAS MARTIN 35.0 X 233498 0 59483 STEPHEN BAJARDI THRU 3312009 35.0 X 63354 0 4605 DOLPH CHIANCHIANO 35.0 X 276818 0 38569 JOSEPH VASSALOTTI 35.0 X 284072 0 54541 GISELE POLITOSKI 35.0 X 245668 0 56949 KERRY WILLIS 35.0 X 206961 0 45663 JOAN SHEPARD LUSTIG 35.0 X 200806 0 30003 JOANN VECCHIONE 35.0 X 187584 0 51702 PRESTON ENGLERT JR 35.0 X 247186 0 41806 INGRID MONTECINO 35.0 X 206398 0 26440 LAWRENCE GEIGER 35.0 X 164243 0 40769 SUZANNE WYCKOFF 35.0 X 157746 0 35343 HOLLY DEVAN 35.0 X 156969 0 39327 3036089 0 759922 44 false true false ADESA IMPACT 13085 HAMILTON CROSSING BLVD SUIT CARMEL IN 46032 FUNDRAISING 995431 TUFTS MEDICAL CENTER 800 WASHINGTON STREET BOX 453 BOSTON MA 02111 GUIDELINES DEVELOP. 852572 MINNEAPOLIS MEDICAL RESEARCH 914 SOUTH 8TH STREET SHAPIRO BLDG MINNEAPOLIS MN 55404 CKD SCREENINGS 749475 QUEST DIAGNOSTICS PO BOX 12989 CHICAGO IL 60693 MEDICAL TESTING 417969 C SYSTEMS INC 510 THORNALL STREET EDISON NJ 08837 CONSULTING 330653 12 794738 10778734 17602993 5407035 29176465 GRANT AND CONTRACT REVENUE 611600 4157238 4157238 KEEP GRANTS AND CONTRACT REVENUE 621990 3711901 3711901 SPONSORSHIPS 611600 2013137 2013137 THRIFT STORE REVENUE 448000 968253 968253 REGISTRATION FEES 611600 709120 709120 3902800 3378749 524051 15462449 181426 181426 0 1975380 1975380 7493248 5407035 7493248 6717730 -1310695 -1310695 -1310695 1974180 10778734 1974180 0 0 329992 100281 229711 229711 MISCELLANEOUS REVENUE 611710 425655 425655 425655 46140391 12612374 4351552 0 4775640 4775640 0 0 3433431 2461427 823680 148324 0 13866643 9943608 3323525 599510 461443 330809 110700 19934 2056139 1473553 492355 90231 1423900 1020794 341594 61512 0 48127 34269 11335 2523 126679 90816 30390 5473 232895 197649 29868 5378 995431 995431 69396 22198 47198 1974944 1652453 257131 65360 1190928 473090 52989 664849 3541278 3023844 500867 16567 474455 333718 101809 38928 3149 1964 80 1105 2568734 1839723 613289 115722 1578865 1119353 235509 224003 0 2633588 970573 44276 1618739 32340 23164 7751 1425 0 367193 263240 88090 15863 266223 155086 50559 60578 SPECIAL PROJECTS - PROGRAMS 8422460 8422460 SPECIAL PROJECTS - MARKETING 1106014 1106014 TRANSPLANT GAMES 467595 467595 DUES AND SUBSCRIPTIONS 57816 40221 11231 6364 TAXES 6418 4601 1540 277 339985 85261 -26493 281217 52521709 40333123 7149273 5039313 7300 5650 2964617 2208975 2237872 2864138 883279 517702 494011 559806 873049 1042589 2381166 1710247 898072 670919 10615017 10426175 2865445 2973596 21838662 21269550 7556479 8437664 3673771 7854112 11230250 16291776 X -800010 -8248746 10403031 11875562 1005391 1350958 10608412 4977774 21838662 21269550 X false true true X false X 8456568 12858895 15127948 23570061 28044857 88058329 8456568 12858895 15127948 23570061 28044857 88058329 88058329 1829901 2192525 2405401 2082885 2156806 10667518 257618 212130 246367 716115 -82355 -82355 99359607 86982180 0.88626 0.90537 X 31078 201817 232895 47249501 47482396 1000000 250000 1000000 1000000 1000000 1000000 4000000 6000000 105074 173244 472593 232895 983806 250000 250000 250000 250000 1000000 1500000 18989 26382 15000 31078 91449 8830253 667192 854414 964122 9387737 11926721 381012 -2992846 484634 8830253 0.14391 0.85609 true false 248457 177691 70766 214341 114581 99760 1918368 1417975 500393 670919 DUE FROM AFFILIATES 2434096 REMAINDER TRUSTS & ESTATES 452715 OTHER ASSETS 86785 2973596 46140391 52521709 -6381318 750680 -951233 -200553 -6581871 49245732 750680 166027 2210832 3127539 46118193 22198 22198 46140391 55827603 166027 3162065 3328092 52499511 22198 22198 52521709 PART V, LINE 4: THE ORGANIZATION'S PERMANENTLY RESTRICTED ENDOWMENT CONSISTS OF PERMANENTLY RESTRICTED NET ASSETS HELD PRIMARILY FOR RESEARCH AND PATIENT SUPPORT. THE REMAINING PORTION OF THE DONOR-RESTRICTED ENDOWMENT FUND THAT IS NOT CLASSIFIED IN PERMANENTLY RESTRICTED NET ASSETS IS CLASSIFIED AS TEMPORARILY RESTRICTED NET ASSETS UNTIL THOSE AMOUNTS ARE EXPENDED AND RELEASED FROM RESTRICTIONS. PART XI, LINE 8: NET DEFICIT ON RELATED ORGANIZATIONS, CAMP REYNAL AND KIDNEY DISEASE IMPROVING GLOBAL OUTCOMES. PART XII, LINE 2D: REVENUES OF RELATED ORGANIZATIONS, CAMP REYNAL AND KIDNEY DISEASE IMPROVING GLOBAL OUTCOMES, IN THE AMOUNT OF $2,110,551, AND COST OF GOODS SOLD IN THE AMOUNT OF $100,281. PART XIII, LINE 2D: EXPENSES OF RELATED ORGANIZATIONS, CAMP REYNAL AND KIDNEY DISEASE IMPROVING GLOBAL OUTCOMES, IN THE AMOUNT OF $3,061,784, AND COST OF GOODS SOLD IN THE AMOUNT OF $100,281. X X X X X X true ADESA IMPACT KIDNEY CARS PROGRAM true 4208424 995431 3212993 4208424 995431 3212993 AL AR CA CO CT DC FL GA IL KS ME MD MA MI MN MS MO NH NJ NM NY NC OH OK OR PA RI SC TN UT VA WA WV WI CHILI COOKOFF 1096829 1096829 -46250 46250 GIFT OF LIFE 999104 508815 490289 0 490289 150 10656981 9173090 1483891 391524 1092367 12752914 10778734 1974180 345274 1628906 1974180 true RESEARCH FELLOWSHIP GRANTS 74 1983648 PATIENT ASSISTANCE GRANTS 2774 1567807 YOUNG INVESTIGATOR RESEARCH GRANTS 18 1062500 CLINICAL SCIENTIST RESEARCH GRANTS 2 87500 PROFESSIONAL COUNCIL RESEARCH GRANTS 11 35015 SCHOLARSHIPS TO KIDNEY PATIENTS 18 24354 TRAVEL GRANTS TO KIDNEY PATIENTS 7 14816 PART I, LINE 2: THE ORGANIZATION'S MOST SIGNIFICANT GRANTS ARE FOR NEPHROLOGY RESEARCH AND INCLUDE CLINICAL SCIENTIST GRANTS, YOUNG INVESTIGATOR GRANTS, RESEARCH FELLOWSHIP GRANTS, AND PROFESSIONAL COUNCIL GRANTS. THE ORGANIZATION HAS ESTABLISHED A RESEARCH AWARD COMMITTEE TO REVIEW APPLICATIONS AND SELECT RESEARCH FELLOWS ON AN ANNUAL BASIS. THE ORGANIZATION CLOSELY MONITORS THE USE OF GRANT FUNDS. EACH AWARDEE IS REQUIRED TO SUBMIT AN ANNUAL PROGRESS REPORT. EACH ADDITIONAL YEAR OF FUNDING IS CONTINGENT UPON APPROVAL AND REVIEW OF THE ANNUAL PROGRESS REPORT AND AVAILABILITY OF FUNDS. UPON COMPLETION OF THE LAST YEAR OF THE GRANT, A FINAL REPORT MUST BE SUBMITTED BY THE AWARDEE. THE ORGANIZATION ALSO PROVIDES GRANTS, SCHOLARSHIPS AND PATIENT ASSISTANCE TO PERSONS WITH KIDNEY DISEASE. X X X X X false true false false false false false false false JOHN R DAVIS 404786 0 194743 0 39979 0 639508 0 DOLPH CHIANCHIANO 276818 0 20873 0 17696 0 315387 0 THOMAS MARTIN 233498 0 21943 0 37540 0 292981 0 JOSEPH VASSALOTTI 284072 0 31931 0 22610 0 338613 0 GISELE POLITOSKI 245668 0 32705 0 24244 0 302617 0 KERRY WILLIS 206961 0 19105 0 26558 0 252624 0 JOAN SHEPARD LUSTIG 200806 0 23938 0 6065 0 230809 0 JOANN VECCHIONE 187584 0 25180 0 26522 0 239286 0 PRESTON ENGLERT JR 247186 0 18750 0 23056 0 288992 0 INGRID MONTECINO 206398 0 15483 0 10957 0 232838 0 LAWRENCE GEIGER 164243 0 12835 0 27934 0 205012 0 SUZANNE WYCKOFF 157746 0 21054 0 14289 0 193089 0 HOLLY DEVAN 156969 0 12254 0 27073 0 196296 0 PART I, LINE 4B: THE ORGANIZATION HAS A SECTION 457(F) SENIOR STAFF FLEXIBLE BENEFIT PLAN THAT PROVIDES SENIOR MANAGEMENT EMPLOYEES WITH A BENEFIT ALLOWANCE CONTRIBUTED BY THE ORGANIZATION, WHICH CAN BE USED FOR VARIOUS BENEFIT OPTIONS, INCLUDING A CAPITAL ACCUMULATION ACCOUNT. IN ADDITION, JOHN R. DAVIS, CEO, PARTICIPATES IN A SUPPLEMENTAL EXECUTIVE RETIREMENT PLAN. X 7905 5407035 FAIR MARKET VALUE false true true PART I, LINE 32B: THE ORGANIZATION CONTRACTS WITH ADESA IMPACT TO ADVERTISE FOR THE DONATION OF VEHICLES AND TO RECEIVE AND DISPOSE OF THE DONATED VEHICLES ON BEHALF OF THE ORGANIZATION. THE ORGANIZATION USED THE NUMBER OF ITEMS CONTRIBUTED FOR CARS AND VEHICLES. FORM 990, PART III, LINE 4D: 1) PUBLIC HEALTH EDUCATION - ATTRACTING 5,250,000 VISITORS IN 2010, THE ORGANIZATION'S WEBSITE, WWW.KIDNEY.ORG, CONTINUED TO EDUCATE AND SERVE AS A RICH RESOURCE ON KIDNEY DISEASE. MEDICAL INFORMATION SEEKERS FLOODED OUR A-Z HEALTH GUIDE PAGES FOR COMPREHENSIVE DATA ON A VARIETY OF KIDNEY CONDITIONS AND ISSUES, INCLUDING NUTRITION AND TREATMENT OPTIONS. MORE THAN 7,000 TESTED THEIR KIDNEY IQ WITH OUR ONLINE KIDNEY QUIZ. E-KIDNEY, THE ORGANIZATION'S MONTHLY E-NEWSLETTER, OFFERED NEWS, KIDNEY-HEALTHY RECIPES AND STORIES OF COURAGE TO NEARLY 35,000 PEOPLE. E-KIDNEY READERSHIP ROSE 40% THIS YEAR. KIDNEY NEWS DAILY, A DAILY E-NEWSLETTER, DELIVERED BREAKING NEWS FROM THE PRINT, BROADCAST AND ONLINE MEDIA TO THOUSANDS IN THE KIDNEY CARE COMMUNITY. THE ORGANIZATION CONTINUES TO FOCUS ON EDUCATING GROUPS WITH HIGH RISK OF KIDNEY DISEASE. NEARLY HALF OF AFRICAN AMERICANS HAVE AT LEAST ONE RISK FACTOR FOR KIDNEY DISEASE, BUT LESS THAN 3% BELIEVE THAT CHRONIC KIDNEY DISEASE IS A "TOP HEALTH CONCERN", ACCORDING TO A REPORT RELEASED THIS YEAR IN THE AMERICAN JOURNAL OF KIDNEY DISEASES, THE OFFICIAL NKF JOURNAL. SINCE AFRICAN AMERICANS WITH CKD PROGRESS MORE QUICKLY TO KIDNEY FAILURE, THE ORGANIZATION DOUBLED ITS EFFORTS TO REACH OUT TO THIS GROUP WITH INFORMATION AND FREE SCREENINGS HELD IN CHURCHES, SCHOOLS AND COMMUNITY CENTERS IN AFRICAN-AMERICAN NEIGHBORHOODS. EXPENSES: $5,769,916. GRANTS: $14,816. REVENUE: $91,933. 2) RESEARCH - RESEARCH REPRESENTS ONE OF THE ORGANIZATION'S TOP PRIORITIES. THE ORGANIZATION GRANTED OVER 60 RESEARCH GRANTS DURING FISCAL YEAR 2010. RESEARCH PROJECTS INCLUDE IMPROVING TRANSPLANT MEDICATIONS, RESEARCHING CARDIOVASCULAR DISEASE AND KIDNEY DISEASE, FINDING THE CAUSE OF DIABETIC NEPHROPATHY, AND IMPROVING THE DIALYSIS PROCESS. RESEARCH IS BEING CONDUCTED ON HOW TO MINIMIZE THE CHANCES OF ORGAN REJECTION OVER A LONG PERIOD OF TIME. THE ULTIMATE OBJECTIVE OF THIS RESEARCH IS TO CREATE IMPROVED TRANSPLANT MEDICATIONS THAT SPECIFICALLY TARGET CELLS RESPONSIBLE FOR ORGAN REJECTION, THEREBY ENSURING MORE SUCCESSFUL LONG-TERM SURVIVAL OF THE TRANSPLANTED ORGAN. CARDIOVASCULAR DISEASE, ESPECIALLY HEART FAILURE, IS THE LEADING CAUSE OF DEATH FOR KIDNEY PATIENTS. SOME RESEARCH IN THIS AREA IS LOOKING AT HOW VITAMIN D AND THE IMMUNE SYSTEM ARE RELATED TO CARDIOVASCULAR DISEASE IN KIDNEY PATIENTS. THIS STUDY MAY LEAD TO SPECIFIC THERAPEUTIC INTERVENTIONS THAT TARGET INNATE IMMUNE RESPONSES TO PREVENT DAMAGE TO THE VASCULAR SYSTEM. DIABETIC NEPHROPATHY (DN), A SERIOUS AND LIFE-THREATENING PROGRESSIVE KIDENY DISEASE, IS THE MOST COMMON CAUSE OF KIDNEY FAILURE IN THE U.S. DISCOVERING THE MECHANISM BEHIND DN IS THE GOAL OF SOME RESEARCHERS. WITH A BETTER UNDERSTANDING OF WHAT TRIGGERS DN, THERAPEUTIC REGIMENS AIMED AT KIDNEY CELL RESTORATION CAN BE CREATED, WHICH WOULD BE BENEFICIAL FOR PATIENTS WITH TYPE 1 AND TYPE 2 DIABETES. IN THE AREA OF DIALYSIS, THE ORGANIZATION RESEARCHERS HOPE TO FIND SOME ANSWERS ON HOW TO MORE EFFICIENTLY REMOVE PROTEIN-BOUND CHEMICALS THEREBY IMPROVING DIALYSIS ITSELF. OTHER GRANTS ASSISTED THE TRAINING OF YOUNG PHYSICIANS (YOUNG INVESTIGATORS) WHO CONDUCTED THE STUDIES. WITH A ROBUST RESEARCH PROGRAM, IMPROVED TREATMENTS FOR CHRONIC KIDNEY DISEASE, MORE SUCCESSFUL TRANSPLANTS AND ADDITIONAL METHODS OF EARLY DETECTION AND PREVENTION MAY BE ON THE HORIZON IN THE NEAR FUTURE. EXPENSES: $4,532,415. GRANTS: $3,156,971. REVENUE: $1,438,016. FORM 990, PART VI, SECTION B, LINE 11A: THE ORGANIZATION'S BOARD OF DIRECTORS ASSIGNS THE AUDIT COMMITTEE THE OVERSIGHT RESPONSIBILITY OF THE IRS FORM 990 AND ITS SUPPLEMENTAL SCHEDULES. FORM 990 IS REVIEWED BY THE CHIEF EXECUTIVE OFFICER, CHIEF FINANCIAL OFFICER, AND AUDIT COMMITTEE PRIOR TO FILING. THE FINAL AND SIGNED FORM 990 IS MADE AVAILABLE TO THE BOARD OF DIRECTORS. FORM 990, PART VI, SECTION B, LINE 12C: TO IDENTIFY CONFLICTS OF INTEREST, OFFICERS, DIRECTORS (GOVERNING BOARD MEMBERS) AND SENIOR STAFF MUST ANNUALLY DISCLOSE ANY POTENTIAL CONFLICTS OF INTEREST. THE ORGANIZATION'S AUDIT COMMITTEE AND THE COMPLIANCE OFFICER MANAGES THE DISCLOSURE AND MONITORING PROCESSES RELATED TO POTENTIAL CONFLICTS OF INTEREST. EACH PERSON ALSO HAS THE RESPONSIBILITY TO REPORT HIS OR HER OWN CONFLICTS OF INTEREST, WHETHER ACTUAL OR PERCEIVED, WHEN SUCH CONFLICTS ARISE DURING A MEETING. AFTER DISCLOSURE OF THE MATERIAL FACTS, THE INDIVIDUAL SHALL LEAVE THE BOARD OR COMMITTEE MEETING WHILE THE POTENTIAL CONFLICT OF INTEREST IS DISCUSSED AND DETERMINED. THE DISCLOSURE, DECISIONS MADE, AND ACTIONS TAKEN ARE DOCUMENTED IN THE MINUTES OF THE MEETING. FORM 990, PART VI, SECTION B, LINE 15A: THE COMPENSATION COMMITTEE IS RESPONSIBLE FOR ESTABLISHING GUIDELINES AND APPROVING COMPENSATION FOR THE CHIEF EXECUTIVE OFFICER ON AN ANNUAL BASIS. THE COMPENSATION COMMITTEE USES AN INDEPENDENT CONSULTANT AND COMPENSATION BENCHMARK STUDIES TO DETERMINE COMPENSATION FOR THE CHIEF EXECUTIVE OFFICER. FORM 990, PART VI, SECTION B, LINE 15B: THE COMPENSATION COMMITTEE IS RESPONSIBLE FOR ESTABLISHING GUIDELINES AND APPROVING COMPENSATION FOR SENIOR MANAGEMENT POSITIONS ON AN ANNUAL BASIS. THE COMPENSATION COMMITTEE USES AN INDEPENDENT CONSULTANT AND COMPENSATION BENCHMARK STUDIES TO DETERMINE COMPENSATION FOR SENIOR MANAGEMENT. THE CHIEF EXECUTIVE OFFICER IS RESPONSIBLE FOR THE INDIVIDUAL PERFORMANCE EVALUATIONS OF SENIOR MANAGEMENT AND DETERMINES MERIT INCREASES AND/OR BONUSES WITHIN GUIDELINES ESTABLISHED BY THE COMPENSATION COMMITTEE. FORM 990, PART VI, SECTION C, LINE 19: THE ORGANIZATION MAKES CERTAIN GOVERNING DOCUMENTS AVAILABLE TO THE PUBLIC THROUGH ITS WEBSITE, WWW.KIDNEY.ORG. SUCH DOCUMENTS INCLUDE THE AUDITED FINANCIAL STATEMENTS, ANNUAL REPORTS, CONFLICT OF INTEREST POLICY, IRS DETERMINATION LETTER AND THE MOST RECENT FORM 990. OTHER GOVERNING DOCUMENTS ARE AVAILABLE UPON REQUEST TO THE COMPLIANCE OFFICER. CAMP REYNAL INC 5429 LBJ FREEWAY SUITE 250 DALLAS TX 75240 061738038 CHILDREN CAMP TX 501(C)(3) 7 KDIGO PATIENT CARE BE N/A N/A false true false true false false false false false false true false true true false false false false KDIGO B 1002626 KDIGO K 1974282 KDIGO N 968072